Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

Cited In for PubMed (Select 19470613)


The Parvalbumin/Somatostatin Ratio Is Increased in Pten Mutant Mice and by Human PTEN ASD Alleles.

Vogt D, Cho KK, Lee AT, Sohal VS, Rubenstein JL.

Cell Rep. 2015 May 12;11(6):944-56. doi: 10.1016/j.celrep.2015.04.019. Epub 2015 Apr 30.


mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.

Nguyen LH, Brewster AL, Clark ME, Regnier-Golanov A, Sunnen CN, Patil VV, D'Arcangelo G, Anderson AE.

Epilepsia. 2015 Apr;56(4):636-46. doi: 10.1111/epi.12946. Epub 2015 Mar 6.


mTOR inhibition in epilepsy: rationale and clinical perspectives.

Ostendorf AP, Wong M.

CNS Drugs. 2015 Feb;29(2):91-9. doi: 10.1007/s40263-014-0223-x.


Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive.

Williams MR, DeSpenza T Jr, Li M, Gulledge AT, Luikart BW.

J Neurosci. 2015 Jan 21;35(3):943-59. doi: 10.1523/JNEUROSCI.3144-14.2015.


Astrocyte activation is suppressed in both normal and injured brain by FGF signaling.

Kang W, Balordi F, Su N, Chen L, Fishell G, H├ębert JM.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2987-95. doi: 10.1073/pnas.1320401111. Epub 2014 Jul 7.


Pathogenetic mechanisms of focal cortical dysplasia.

Marin-Valencia I, Guerrini R, Gleeson JG.

Epilepsia. 2014 Jul;55(7):970-8. doi: 10.1111/epi.12650. Epub 2014 May 23. Review.


Brain patterning perturbations following PTEN loss.

Veleva-Rotse BO, Barnes AP.

Front Mol Neurosci. 2014 May 14;7:35. doi: 10.3389/fnmol.2014.00035. eCollection 2014. Review.


Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation.

Lasarge CL, Danzer SC.

Front Mol Neurosci. 2014 Mar 14;7:18. doi: 10.3389/fnmol.2014.00018. eCollection 2014. Review.


Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures.

Weston MC, Chen H, Swann JW.

Front Mol Neurosci. 2014 Feb 3;7:1. doi: 10.3389/fnmol.2014.00001. eCollection 2014.


mTOR Strikes Again: mTORC1 Activation Causes Epilepsy Independent of Overt Pathological Changes.

Wong M.

Epilepsy Curr. 2014 Jan;14(1):41-3. doi: 10.5698/1535-7597-14.1.41. No abstract available.


Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.

Chang P, Walker MC, Williams RS.

Neurobiol Dis. 2014 Feb;62:296-306. doi: 10.1016/j.nbd.2013.10.017. Epub 2013 Oct 19.


Disentangling hippocampal shape anomalies in epilepsy.

Kim H, Mansi T, Bernasconi N.

Front Neurol. 2013 Sep 11;4:131. doi: 10.3389/fneur.2013.00131. eCollection 2013.


High-dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy.

Heng K, Haney MM, Buckmaster PS.

Epilepsia. 2013 Sep;54(9):1535-41. doi: 10.1111/epi.12246. Epub 2013 Jul 12.


A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials.

Wong M.

Expert Rev Neurother. 2013 Jun;13(6):657-69. doi: 10.1586/ern.13.48. Review.


mTOR Inhibitors in Tuberous Sclerosis Complex.

Curatolo P, Moavero R.

Curr Neuropharmacol. 2012 Dec;10(4):404-15. doi: 10.2174/157015912804143595.


Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury.

Guo D, Zeng L, Brody DL, Wong M.

PLoS One. 2013 May 14;8(5):e64078. doi: 10.1371/journal.pone.0064078. Print 2013.


How does the ketogenic diet work? Four potential mechanisms.

Danial NN, Hartman AL, Stafstrom CE, Thio LL.

J Child Neurol. 2013 Aug;28(8):1027-33. doi: 10.1177/0883073813487598. Epub 2013 May 13.


Mammalian target of rapamycin (mTOR) pathways in neurological diseases.

Wong M.

Biomed J. 2013 Mar-Apr;36(2):40-50. doi: 10.4103/2319-4170.110365. Review.


mTOR as a potential treatment target for epilepsy.

Wong M.

Future Neurol. 2012 Sep 1;7(5):537-545.


Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder.

Parker WE, Orlova KA, Parker WH, Birnbaum JF, Krymskaya VP, Goncharov DA, Baybis M, Helfferich J, Okochi K, Strauss KA, Crino PB.

Sci Transl Med. 2013 Apr 24;5(182):182ra53. doi: 10.1126/scitranslmed.3005271.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk